Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Adaptative immunity (T cells and B cells) in rheumatic diseases
THU0499 Hm71224, A Novel Oral BTK Inhibitor, Inhibits Human Immune Cell Activation: New Drug Candidate to Treat B-Cell Associated Autoimmune Diseases
Compose a Response to This Article
Other responses
No responses have been published for this article.